Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pembrolizumab with Chemotherapy in SCCOHT
NCT04602377Phase 2Recruiting
- Sponsor
- ARCAGY
- Start
- Aug 2021
- Primary completion
- Jun 2026
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pembrolizumab in small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), sponsored by ARCAGY. Started Aug 2021; status: recruiting.
02
Drugs
03
Conditions
small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)
Beyond the preview
Go deeper on NCT04602377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04602377.